Integrating knowledge across disciplines and taxonomic boundaries.
14-21.06.2025 Basil and Maya attend a Summer School in Guarda about Evolutionary Biology, meeting current and future legends in the field
24.3.2025 Barbora speaks in Kastanienbaum Eawag location
3-10.3.2025 Maya visiting FU Berlin
13-14.2.2025 Basil, Maya and Viktor attend Biology25 meeting.
20.2.2025 Let's go Ice-skating!
29.1.2025: Viktor introduced himself at Ecomeets!
29.1.2025: Viktor lead the first 'Skill sharing' meeting at 3 pm, in NO building.
23.1.2025: We just had our first official group meeting.
20.1.2025: Our group is finally complete!
1.1.2025: Viktor Kovalov started a postdoctoral position and Aryan Golzaryan stared his PhD in Pathogen Evolution research group.
6.11.2025: Barbora introduces the group at EcoMeets
1.11.2024: Basil Vogelsanger started his PhD in Pathogen Evolution research group.
1.10.2024: Maya Louage started her PhD in Pathogen Evolution research group.
1.9.2024: The Pathogen Evolution research group founded!
We develop a computational framework to investigate drug resistance evolution that integrates knowledge across disciplines,
from human health studies through veterinary medicine to agriculture, as well as across taxonomic
boundaries and hosts.
We focus on drug resistance evolution in three major contributors to disease burden worldwide - bacteria, fungi, and helminths.
Throughout history, bacteria have caused countless fatal diseases. Yet, in recent decades, antibiotics revolutionized treatment. However, bacteria's rapid evolution, fueled by large populations and widespread antibiotic use, leads to alarming resistance, with no antibiotic being spared. We may be facing a dangerous post-antibiotic era where once-treatable diseases threaten lives again.
Helminths, especially nematodes, infect plants, animals, and humans alike. Even with advances in sanitation, they persist as some of the most common infections globally, disproportionately affecting those in poverty. The CDC estimates one billion Ascaris infections alone. Even though the diseases they cause can be fatal, they belong to the Neglected Tropical Diseases group – underfunded and often overlooked on the global health agenda.
Anthelminthic drugs are typically effective, but their overuse in livestock has led to the rise of drug-resistant strains. This resistance is a growing global problem, harming agriculture and posing a zoonotic threat with implications for One Health initiatives.
Though less publicized than bacterial diseases, fungal infections (mycoses) are a major threat, especially fatal to immunocompromised individuals. In addition, mycoses are especially common in plants, affecting farm production worldwide, causing mass devastation of crops and threatening food security.
However, resistance to many fungicides has already emerged and spread in pathogen populations. Moreover, the time to resistance evolution has been shown to decrease: the later the drug was introduced, the shorter the time until the resistance was recorded.
The escalating threat of drug resistance is a global crisis. Bacteria, fungi, macroscopic parasites, and viruses are constantly adapting to evade drug treatments, leading to devastating human losses and crippling economic costs in agriculture.
Though drug resistance is primarily viewed through a human health lens, the largest volume of drug use occurs in agriculture. The One Health framework reveals the connections between human, animal, and ecosystem health. Our increasing dependence on animals strengthens this link, making the spread of pathogens – and drug resistance – more likely.
We aim to collect, map, and analyze the existing knowledge of pharmacodynamic data relevant for drug resistance modeling from various disciplines, from human through veterinary medicine to agriculture.
We aim to develop a modular model, combining population genetic principles with a pharmacodynamic approach. This will allow us to investigate the role of reproductive strategy, lifestyle and ploidy.
Contact us to get more information about the project